Madrid, Spain

María Jesús Martín López

This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: María Jesús Martín López. Retrieved from https://idiyas.com/inventor/maría-jesús-martín-lópez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of María Jesús Martín López

Introduction

María Jesús Martín López is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer compounds. His work is characterized by a commitment to advancing medical science and improving patient outcomes.

Latest Patents

María Jesús holds a patent for anticancer compounds, specifically compounds of formula (I) and their derivatives. This innovation represents a crucial step in the fight against cancer, showcasing his dedication to addressing critical health challenges.

Career Highlights

He is currently employed at Pharma Mar, S.A., a company renowned for its focus on developing innovative therapies for cancer treatment. His role at Pharma Mar has allowed him to leverage his expertise in medicinal chemistry and contribute to groundbreaking research.

Collaborations

Throughout his career, María Jesús has collaborated with talented professionals, including Raquel Rodríguez Acebes and Patricia Gema Cruz López. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

María Jesús Martín López exemplifies the spirit of innovation in the pharmaceutical industry. His work on anticancer compounds not only highlights his inventiveness but also underscores the importance of collaboration in scientific research. His contributions are paving the way for future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…